Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 25 clinical trials
featured
An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias

An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias

  • 128 views
  • 25 Mar, 2021
  • 1 location
VA-008 ACAM2000 Vaccination of Plasma Donors for the Production of VIGIV

collection of donor plasma will be used in the manufacturing of Vaccinia Immune Globulin Intravenous (VIGIV). To ensure the safety of plasma donors vaccinated with ACAM2000 through the

  • 0 views
  • 07 Mar, 2021
  • 2 locations
Intravenous Gammaglobulin for Sickle Cell Pain Crises

The purpose of this study is to determine whether intravenous immune globulin is safe and effective in the acute treatment of pain crises in sickle cell disease.

  • 40 views
  • 07 Nov, 2020
  • 1 location
Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome

immune globulin (IVIG) and/or steroids will be given intravenous infusions of hCT-MSCs. Doses of 2x10^6 cells/kg (up to a maximum dose of 100x10^6 cells) will be given on days 1, 2, 3, +/-7 (day 7 is

  • 0 views
  • 24 Mar, 2021
  • 3 locations
IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load

with a total dose of 2 g/kg of immune globulin administered as 0.5 g/kg IV over a period of 6 hours on each of 4 consecutive days. Main study parameters/endpoints: EMBs: virus (PVB19

ejection fraction
cardiomyopathy
  • 23 views
  • 07 Nov, 2020
  • 1 location
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease

In this study, the investigator plan to prescribe Methylprednisolone pulse therapy in Kawasaki disease patients with coronary artery lesions or aneurysm formation beyond acute stage to investigate the role for vasculitis of KD or regression of dilatation.

methylprednisolone pulse therapy
vasculitis
coronary artery aneurysm
igiv
aneurysm
  • 25 views
  • 25 Jan, 2021
  • 1 location
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma 5% DIF in Patients With Post-polio Syndrome

This is a multicenter, prospective, randomized, placebo-controlled, double-blind, parallel group clinical trial with adaptive dose selection in subjects with post polio syndrome (PPS). The main purpose of this study is to select a dose of Flebogamma 5% DIF and confirm the efficacy of the selected Flebogamma 5% DIF dose by …

  • 167 views
  • 29 Jan, 2021
  • 56 locations
Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP

The purpose of this phase IIIb study is to assess the long-term safety, tolerability, and immunogenicity of the subcutaneous (SC) treatment with Immune Globulin Subcutaneous (IGSC) facilitated

polyradiculoneuropathy
immune globulin
hyqvia
immunoglobulins
recombinant human hyaluronidase
  • 220 views
  • 01 Feb, 2021
  • 51 locations
A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety

This is a Phase III, blinded, randomized study of SYN023 compared to a China licensed Human Rabies Immunoglbulin (a Rabies immune globulin from human sources, HRIG) for the prevention of rabies

  • 0 views
  • 27 Jan, 2021
  • 1 location
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

This randomized phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual disease-negative mantle cell lymphoma in first complete remission. Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells …

prednisone
doxorubicin
cell transplantation
cyclophosphamide
cancer
  • 258 views
  • 25 Jan, 2021
  • 235 locations